Berenberg Initiates Bristol-Myers Squibb With Hold

Berenberg initiated coverage on Bristol-Myers Squibb Co BMY with a Hold rating. The target price for Bristol-Myers Squibb is set to $70. Bristol-Myers Squibb shares have gained 29.32 percent over the past 52 weeks, while the S&P 500 index has surged 11.12 percent in the same period. Bristol-Myers Squibb shares fell 3.12 percent to $65.30 in pre-market trading.